explore -WSS

explore

author：focus 2025-09-28 23:49:20 - browse：857

Adam's take main illustration — Molly Ferguson/STAT

Shares of Apellis Pharmaceuticals are rebounding, driven by a growing belief among some investors that the serious safety issue that has derailed Syfovre, the company’s eye disease treatment, is receding.

Declaring the crisis over is premature, but that could change with more uneventful weeks. Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value.

Apellis shares rose 32% last week, with most of the gains coming Friday on heavy trading volume. The reason: There have been no new cases of retinal occlusive vasculitis, or ROV, reported in people receiving injections of Syfovre.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Fatty liver disease was alleviated by Lilly’s ‘triple

knowledge

WSS

Guardant Health colon cancer test endorsed by FDA advisory panel

J&J reports mixed data on next

A letter from the executive editor: The 2023 STATUS List

Why some fertility treatments produce more boy babies

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

The world needs the new pandemic treaty

explore

explore

entertainment

New air purifier tech could be key to improving indoor air quality

Guardant Health colon cancer test endorsed by FDA advisory panel

Wildfire smoke exposes gaps in outdoor worker protections

Why some fertility treatments produce more boy babies

State Dept. review finds Biden bears some blame for Afghanistan failures

Pharma’s losing bet in New Jersey

Walensky prepares to leave CDC — and Congress — behind

STAT wants to know your pick for a great summer read or listen

New air purifier tech could be key to improving indoor air quality

Guardant Health colon cancer test endorsed by FDA advisory panel

leisure time

Hospitals need to get ahead of regulations on climate change

Stroke rates rising, especially in working

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Should insurance cover cosmetic surgery?

Hubble vs. James Webb telescope images: See the difference

Fatty liver disease was alleviated by Lilly’s ‘triple

knowledge

explore

explore

focus